Vaxart Inc Sustainability Reports
Vaxart Inc. specializes in the development of oral recombinant vaccines using its proprietary delivery technology.
Sector: Health Care
Country: United States
Exchange: Nasdaq Stock Market
ISIN: US92243A2006
3 reports from 2021 to 2024
Company Profile
Vaxart Inc
Vaxart Inc. specializes in the development of oral recombinant vaccines using its proprietary delivery technology.
Reports